中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
9期
32-34
,共3页
赵金花%高志光%刘萍%穆丽雅%王英慧
趙金花%高誌光%劉萍%穆麗雅%王英慧
조금화%고지광%류평%목려아%왕영혜
糖皮质激素%MMP-9%FGF-2%鼻窦炎%鼻息肉
糖皮質激素%MMP-9%FGF-2%鼻竇炎%鼻息肉
당피질격소%MMP-9%FGF-2%비두염%비식육
glucocorticoid%MMP-9%FGF-2%Sinusitis%Nasal polyps
目的:探讨糖皮质激素在鼻内镜术后鼻粘膜重塑中的作用机制。方法60例鼻息肉患者组织中的鼻粘膜病变,鼻内窥镜手术切除是术前组;然后再把鼻息肉内镜术后的患者分成两组:激素组和对照组,前者是在术后进行连续12周的糖皮质激素喷鼻剂喷鼻,2次/d,后者是术后没有应用鼻部药物及全身用药。患者在术后以无菌生理盐水对鼻腔进行冲洗,并定期进行检查,对术腔进行清理。在术后的第1个月和第3个月采集患者的前组筛窦粘膜样本。各次检查均在鼻内镜下,记录检查所见。另取6例鼻中隔下鼻甲手术作为正常对照。用免疫组化法检测,在术后激素组与对照组标本中的MMP-9、FGF-2的蛋白表达,并进行统计学分析。结果正常对照组未见FGF-2、MMP-9的阳性表达,术后第1个月时,激素组与对照组的症状、鼻内镜检查、组织病理学及MMP-9、FGF-2的蛋白表达,差异无统计学意义(P>0.05)。但是在术后第3个月,却出现了上述各指标激素组比对照组有改善显著,鼻部症状出现改善,水肿像对较轻,术腔上皮化趋势明显;免疫组化显示:激素组在阳性炎性细胞中MMP-9、FGF-2蛋白表达,明显低于对照组,差异有统计学意义(t=2.32,P<0.05)。结论糖皮质激素对鼻内镜术后鼻粘膜重塑有明显抑制作用,与MMP-9、FGF-2蛋白表达减少可能有关,早期规范应用糖皮质激素,可促进黏膜上皮化,能减轻并延缓鼻粘膜发生重塑;术后坚持应用糖皮质激素不少于12周。
目的:探討糖皮質激素在鼻內鏡術後鼻粘膜重塑中的作用機製。方法60例鼻息肉患者組織中的鼻粘膜病變,鼻內窺鏡手術切除是術前組;然後再把鼻息肉內鏡術後的患者分成兩組:激素組和對照組,前者是在術後進行連續12週的糖皮質激素噴鼻劑噴鼻,2次/d,後者是術後沒有應用鼻部藥物及全身用藥。患者在術後以無菌生理鹽水對鼻腔進行遲洗,併定期進行檢查,對術腔進行清理。在術後的第1箇月和第3箇月採集患者的前組篩竇粘膜樣本。各次檢查均在鼻內鏡下,記錄檢查所見。另取6例鼻中隔下鼻甲手術作為正常對照。用免疫組化法檢測,在術後激素組與對照組標本中的MMP-9、FGF-2的蛋白錶達,併進行統計學分析。結果正常對照組未見FGF-2、MMP-9的暘性錶達,術後第1箇月時,激素組與對照組的癥狀、鼻內鏡檢查、組織病理學及MMP-9、FGF-2的蛋白錶達,差異無統計學意義(P>0.05)。但是在術後第3箇月,卻齣現瞭上述各指標激素組比對照組有改善顯著,鼻部癥狀齣現改善,水腫像對較輕,術腔上皮化趨勢明顯;免疫組化顯示:激素組在暘性炎性細胞中MMP-9、FGF-2蛋白錶達,明顯低于對照組,差異有統計學意義(t=2.32,P<0.05)。結論糖皮質激素對鼻內鏡術後鼻粘膜重塑有明顯抑製作用,與MMP-9、FGF-2蛋白錶達減少可能有關,早期規範應用糖皮質激素,可促進黏膜上皮化,能減輕併延緩鼻粘膜髮生重塑;術後堅持應用糖皮質激素不少于12週。
목적:탐토당피질격소재비내경술후비점막중소중적작용궤제。방법60례비식육환자조직중적비점막병변,비내규경수술절제시술전조;연후재파비식육내경술후적환자분성량조:격소조화대조조,전자시재술후진행련속12주적당피질격소분비제분비,2차/d,후자시술후몰유응용비부약물급전신용약。환자재술후이무균생리염수대비강진행충세,병정기진행검사,대술강진행청리。재술후적제1개월화제3개월채집환자적전조사두점막양본。각차검사균재비내경하,기록검사소견。령취6례비중격하비갑수술작위정상대조。용면역조화법검측,재술후격소조여대조조표본중적MMP-9、FGF-2적단백표체,병진행통계학분석。결과정상대조조미견FGF-2、MMP-9적양성표체,술후제1개월시,격소조여대조조적증상、비내경검사、조직병이학급MMP-9、FGF-2적단백표체,차이무통계학의의(P>0.05)。단시재술후제3개월,각출현료상술각지표격소조비대조조유개선현저,비부증상출현개선,수종상대교경,술강상피화추세명현;면역조화현시:격소조재양성염성세포중MMP-9、FGF-2단백표체,명현저우대조조,차이유통계학의의(t=2.32,P<0.05)。결론당피질격소대비내경술후비점막중소유명현억제작용,여MMP-9、FGF-2단백표체감소가능유관,조기규범응용당피질격소,가촉진점막상피화,능감경병연완비점막발생중소;술후견지응용당피질격소불소우12주。
objective To investigate the mechanism of glucocorticoid in nasal mucosaremodeling after endoscopic sinus surgery.Methods Nasal mucosal lesions in 60 cases of nasal polyps tissues, nasal endoscopic operation excision as a preoperative group; nasal polypsafter endoscopic surgery in patients with hormone group (equally divided between the two gro ups: postoperative to glucocorticoid nasal spraynasal spray, two, daily for 12 weeks) and control group (nasal drug andsystemic medication without the use of postoperative). Postoperative patients with sterile saline nasal irrigation, debridement, periodic re view,cavity. Article 1,3 months after surgery, review takes its anterior ethmoid sinus mucosa specimens. An inspection under nasal endoscope,recording the findings. Another 6 cases of nasal septum and inferior turbinate surgery as normal control. Was detected byimmunohistochemical method, the expression of MMP-9 and FGF-2proteins in the specimens in the two groups after operation, and carries on statistics analysis.Results First months after operation, the hormone group and the control group of symptoms, nasal endoscopy, pathology and MMP-9, FGF-2 protein expression showed no significant difference. And third months after operation, the hormone group the index group had significant improvement compared with the control, the performance of the nosesymptoms, edema, surgical cavity epithelial trend significantly;immunohistochemistry showed: the quantity of hormone group MMP-9,FGF-2 positive inflammatory cells, significantly lower than the control group, there is statistical significance (t=2.32, P<0.05).Conclusion Corticosteroid on nasal mucosa after endoscopic sinus surgery can significantly inhibit and reduce the role of remodeling, and expression of MMP-9, FGF-2 protein may be related to reduced, reasonable application of glucocorticoids, promotin g mucosa, can reduce and delay the nasal mucosa remodeling; insist on the application of glucocorticoids is not less than12weeks after operation.